Press Releases

  • March 31, 2026

CorWave Strengthens Its Leadership Team with Two Key Appointments – Andreas Fleischli Appointed Chief Technology Officer and Daniel Lexcen Named Vice President Clinical & Scientific Affairs

 

  • September 29, 2025

CorWave Announces Presentation of Late Breaking Results from its First-In-Human Implant at HFSA Annual Scientific Meeting

 

  • July 09, 2025

World First: CorWave’s Undulating Membrane Heart Pump Implanted in First Patient

 

  • April 24, 2025

CorWave Announces Successful Completion of 6-Month Chronic In Vivo Study, Paving the Way for Clinical Trial Initiation.

 

  • April 02, 2025

CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production.

 

  • October 09, 2023

CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris.

 

  • June 20, 2023

CorWave Announces Second Closing of Its Series C Funding at €61M To Finance Its First Industrial Deployment.

 

  • March 17, 2022

CorWave To Set Up Its Manufacturing Facility and Expand To A New Site Next to Paris.

 

  • October 19, 2021

CorWave Wins 2021 HealthTech Award.

 

  • September 21, 2021

CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up.

 

  • June 14, 2021

CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting.

 

  • April 27, 2021

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation.

 

  • February 08, 2021

CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies.

 

  • January 06, 2021

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor.

 

  • November 19, 2020

CorWave Secures a €500,000 Grant From the Paris Region for Its Industrial Facilities.

 

  • July 21, 2020

CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program.

 

  • June 10, 2020

CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting.

 

  • February 11, 2020

CorWave Appoints Jim Schuermann as an Independent Director.

 

  • September 11, 2019

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device.

 

  • June 28, 2019

CorWave To Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device.

 

  • July 10, 2018

CorWave’s next-generation LVAD receives funding.

 

  • July 05, 2018

Corwave Announces Issuance of US Patent Covering Its Implantable Left Ventricular Assist Device Leveraging the Wave Membrane Technology.

 

  • March 16, 2018

CorWave scales up increasing its R&D capabilities and opening a pilot production unit at its new Clichy site.

 

  • March 15, 2018

CorWave is pegged as a potential billion-euro company as part of “Future Unicorn” competition.

 

  • April 03, 2018

CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support.

 

  • November 08, 2017

CorWave Receives 2017 Deloitte ‘Technology Fast 50 Biotech of the Future’ Award of the Parisian Region.

 

  • November 04, 2016

CorWave Raises $17.1 Million in Series B Financing.

 

  • July 22, 2016

CorWave Awarded at the Worldwide Innovation Challenge.

 

  • December 08, 2015

CorWave Presents Promising Early Results for Innovative Wave Membrane Blood Pump.